INTOCELL, INC. revenue breakdown overview

INTOCELL, INC. revenue for the last year amounted to 290.00 M KRW, the most of which — 2.91 B KRW — came from its highest performing source at the moment, Antibody-drug Conjugate, the year earlier bringing 1.62 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought INTOCELL, INC. 2.88 B KRW.